L. Elyamani , N. Benaini , O. Hormi , N. Zerrouki , N. Zizi
{"title":"Érythème pigmenté fixe bulleux généralisé : à propos d’un cas","authors":"L. Elyamani , N. Benaini , O. Hormi , N. Zerrouki , N. Zizi","doi":"10.1016/j.reval.2025.104554","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Generalized bullous fixed drug eruption is a rare and severe form of fixed drug eruption, often induced by cotrimoxazole, which may be confused with Stevens-Johnson syndrome.</div></div><div><h3>Observation</h3><div>A 45-year-old patient with no relevant history developed Generalized bullous fixed drug eruption 8<!--> <!-->hours after taking cotrimoxazole for gastroenteritis. A similar episode localized to the extremities had been reported 5 years earlier, occurring 4 days after taking the same drug. Clinico-pathological correlation led to the diagnosis of Generalized bullous fixed drug eruption. Treatment consisted of discontinuation of cotrimoxazole and local care, resulting in healing of all lesions, with post-inflammatory hyperpigmentation. Reintroduction of the drug was prohibited, and a pharmacovigilance report was made.</div></div><div><h3>Discussion</h3><div>Fixed drug eruption is a drug-induced toxidermia characterized by well-limited skin lesions, recurring at the same site after re-exposure to the causative drug. Generalized bullous fixed drug eruption is a rare and severe form, which can mimic Stevens-Johnson syndrome/toxic epidermal necrolysis, particularly in cases of extensive mucosal involvement. Diagnosis is based on clinico-pathological correlation and a detailed drug history. Treatment consists of discontinuing the causative drug, combined with local care. Topical or systemic corticosteroids may be necessary in severe forms.</div></div><div><h3>Conclusion</h3><div>Erythema pigmentosum fixed bullosa generalizada (EPFBG) is a rare and misunderstood condition. Further efforts are needed to develop more reliable and safer methods for identifying the drugs involved in equivocal situations.</div></div>","PeriodicalId":49130,"journal":{"name":"Revue Francaise d Allergologie","volume":"65 5","pages":"Article 104554"},"PeriodicalIF":0.3000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue Francaise d Allergologie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877032025003264","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Generalized bullous fixed drug eruption is a rare and severe form of fixed drug eruption, often induced by cotrimoxazole, which may be confused with Stevens-Johnson syndrome.
Observation
A 45-year-old patient with no relevant history developed Generalized bullous fixed drug eruption 8 hours after taking cotrimoxazole for gastroenteritis. A similar episode localized to the extremities had been reported 5 years earlier, occurring 4 days after taking the same drug. Clinico-pathological correlation led to the diagnosis of Generalized bullous fixed drug eruption. Treatment consisted of discontinuation of cotrimoxazole and local care, resulting in healing of all lesions, with post-inflammatory hyperpigmentation. Reintroduction of the drug was prohibited, and a pharmacovigilance report was made.
Discussion
Fixed drug eruption is a drug-induced toxidermia characterized by well-limited skin lesions, recurring at the same site after re-exposure to the causative drug. Generalized bullous fixed drug eruption is a rare and severe form, which can mimic Stevens-Johnson syndrome/toxic epidermal necrolysis, particularly in cases of extensive mucosal involvement. Diagnosis is based on clinico-pathological correlation and a detailed drug history. Treatment consists of discontinuing the causative drug, combined with local care. Topical or systemic corticosteroids may be necessary in severe forms.
Conclusion
Erythema pigmentosum fixed bullosa generalizada (EPFBG) is a rare and misunderstood condition. Further efforts are needed to develop more reliable and safer methods for identifying the drugs involved in equivocal situations.
期刊介绍:
La Revue Française d''Allergologie : un véritable forum pour faire connaître des travaux originaux et permettre la diffusion de l''information auprès de toutes les spécialités concernées par les pathologies allergiques. La Revue Française d''Allergologie (8 numéros par an) est au carrefour de nombreuses spécialités - dermatologie, pédiatrie, ORL, pneumologie, ophtalmologie, médecine interne - qui, toutes, ont à traiter des maladies allergiques. Les symptômes des allergies fondés sur des mécanismes communs sont le plus souvent associés et se succèdent chez un même patient. En forte progression depuis 20 ans, les maladies allergiques sont dans l''attente de perfectionnements et d''avancées thérapeutiques qui permettront aux nombreux patients qui en sont atteints de mieux vivre avec leurs allergies. La Revue Française d''Allergologie se veut donc un véritable forum de discussions et d''échanges entre tous les spécialistes confrontés aux pathologies